Status
Conditions
Treatments
About
Newborns with congenital heart disease (CHD) are at increased risk of developing postpartum and postoperative blood clots after cardiac surgery. The molecular mechanisms that are responsible for the clotting profile predisposing children to blood clots in the early stages of life are currently not well described.
The goal of this proposal is to prospectively collect plasma samples from ten (10) neonates with antenatal diagnosis of severe congenital heart disease (CHD) to better understand mechanisms responsible for abnormal clotting in the perioperative period.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
10 participants in 1 patient group
Loading...
Central trial contact
Rachel Bernier, MPH; Hanna Van Pelt, BS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal